Printer Friendly
The Free Library
14,599,499 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

AngioDynamics to Hold Fiscal 2006 Second Quarter Financial Results Conference Call on Monday, December 19, 2005.


QUEENSBURY, N.Y. -- AngioDynamics, Inc. (Nasdaq:ANGO ANGO Algemene Nederlandse Gehandicapten Organisatie (Dutch: Equal Opportunities for Persons with Disabilities) ) today announced that the company will release fiscal 2006 second quarter results after the market closes on Monday, December 19, 2005.

Eamonn P. Hobbs, president and chief executive officer, and Joseph G. Gerardi, chief financial officer, will host an investment community conference call beginning at 4:30 p.m. Eastern Time on December 19 to discuss these results and to answer questions.

To participate in the live call by telephone, please dial 866-578-5747 from the U.S., or for international callers, please dial 617-213-8054. Please enter the passcode 53147624.

Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations Investor relations

The process by which the corporation communicates with its investors.
 section of AngioDynamics' web site at http://investor.angiodynamics.com/. To listen to the live call, please go to the web site 15 minutes prior to its start to register, download, and install the necessary audio software.

A replay will be available on the web site. A telephone replay will be available from 6:30 p.m. Eastern Time on December 19, 2005 through 11:59 p.m. Eastern Time on December 26, 2005 by dialing 888-286-8010 (domestic) or 617-801-6888 (international) and entering conference ID number 30654415.

The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at www.earnings.com, Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents (www.streetevents.com), a password-protected event management site.

About AngioDynamics

AngioDynamics, Inc. (www.angiodynamics.com) is a leading provider of innovative medical devices used by interventional radiologists, vascular surgeons and other physicians for the minimally invasive diagnosis and treatment of peripheral vascular disease Peripheral Vascular Disease Definition

Peripheral vascular disease is a narrowing of blood vessels that restricts blood flow. It mostly occurs in the legs, but is sometimes seen in the arms.
. AngioDynamics, Inc. designs, develops, manufactures and markets a broad line of therapeutic and diagnostic devices that enable interventional physicians, such as interventional radiologists, vascular surgeons and others, to treat peripheral vascular diseases and other non-coronary diseases. The Company's diverse product line includes angiographic catheters, hemodialysis catheters, endovascular laser venous system products, PTA PTA or parent-teacher association: see parent education.  dilation dilation /di·la·tion/ (di-la´shun)
1. the act of dilating or stretching.

2. dilatation.


di·la·tion
n.
1.
 balloon catheters, image-guided vascular access vascular access Clinical medicine The ability to enter the vascular system; the ease with which the vascular system can be entered for administering therapy or obtaining blood for testing  products, thrombolytic thrombolytic /throm·bo·lyt·ic/ (throm?bo-lit´ik) dissolving or splitting up a thrombus, or an agent that so acts.

thrombolytic

1. dissolving or splitting up a thrombus.

2. an agent that dissolves or splits up a thrombus.
 products and drainage products.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Dec 13, 2005
Words:348
Previous Article:Merck Announces US Label Change for SINGULAIR(R) (Montelukast Sodium): New Growth Data in Children; Clinical Study Shows Children Taking SINGULAIR...
Next Article:Netuitive Releases Latest Version of Its Real-Time Analysis Management Software; Leading Self-Learning Software Includes New Features Dramatically...
Topics:



Related Articles
AngioDynamics Fiscal Fourth Quarter Operating Profit up 31% on 23% Increase in Net Sales; Fiscal Year 2005 Net Sales Top a Record $60 Million; Net...
AngioDynamics Reports Net Income Up 70% On 25% Revenue Gain; Conference Call to Begin Today At 4:30 pm ET.
AngioDynamics Net Income Up 60% on 30% Increase to Record Net Sales in Second Quarter of Fiscal 2006; Conference Call to Begin Today at 4:30 pm ET.
AngioDynamics Third Quarter Net Income up 73% on Record Revenue; Company Revises Financial Guidance Upwards; Conference Call Begins Today at 4:30...
AngioDynamics to Hold Fiscal 2006 Fourth Quarter Financial Results Conference Call on Thursday, August 10, 2006.
AngioDynamics Fourth Quarter Results Feature Net Sales up 36%; Company Introduces Fiscal 2007 Financial Guidance; Conference Call Begins Today at...
AngioDynamics to Hold Fiscal 2007 First Quarter Financial Results Conference Call on Monday, September 25, 2006.
AngioDynamics Reports Record First Quarter Sales and Earnings.
AngioDynamics to Acquire RITA Medical for $220 Million.
AngioDynamics Reports Record Second Quarter Sales and Net Income.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles